KENS 5: UT Health studies vitamin to treat acute kidney injury caused by COVID-19

August 17, 2021

Dr. Kumar Sharma, Department of Medicine/Division of Nephrology/Center for Renal Precision Medicine, is quoted in this KENS 5 story about a study that aims to reduce the severity of acute kidney disease in patients with COVID-19 using a form of a vitamin. Watch story

Yahoo!: Can a vitamin treat COVID-19-related acute kidney injury?

August 3, 2021

Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on Yahoo.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story

IQ Stock Market: Can a vitamin treat COVID-19-related acute kidney injury?

August 3, 2021

Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on IQ Stock Market.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story

BizWire Express: Can a vitamin treat COVID-19-related acute kidney injury?

August 3, 2021

Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on BizWire Express.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story

ADVFN.com: Can a vitamin treat COVID-19-related acute kidney injury?

August 3, 2021

Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on ADVFN.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story

TD Ameritrade: Can a vitamin treat COVID-19-related acute kidney injury?

August 3, 2021

Dr. Kumar Sharma, Department of Medicine, Division of Nephrology and Center for Renal Precision Medicine, and Dr. Subrata Debnath, Nephrology, are quoted in this news release disseminated on TD Ameritrade.com about NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury in COVID-19 patients. Read story